Yonghe Medical Group Co., Ltd. (Yonghe Medical, 02279) has issued a notice convening its 2026 Annual General Meeting (AGM) for 2:00 p.m. on 19 May 2026 at the KunTai International Building in Beijing.

Key proposals to be put before shareholders include:

1. Financial Statements and Dividend • Adoption of the audited consolidated financial statements and Board and auditor reports for the year ended 31 December 2025. • Declaration of a final dividend of RMB0.076 (approximately HK$0.086) per share, excluding treasury shares. Shareholders recorded by 27 May 2026 will be eligible; the register will be closed from 28 May to 29 May 2026.

2. Board Composition and Remuneration • Re-election of one executive director (Mr. Zhang Yu) and three independent non-executive directors (Ms. Liang Jihong, Mr. Chan Peng Kuan and Mr. Li Xiaopei). • Authorisation for the Board to determine directors’ remuneration.

3. Auditor Appointment • Re-appointment of PricewaterhouseCoopers as external auditor and authorisation for the Board to set its remuneration.

4. Share Capital Mandates • General mandate allowing the Board to repurchase up to 10% of issued shares (excluding treasury shares) during the mandate period. • General mandate permitting issuance, allotment or dealing of up to 20% of issued shares (excluding treasury shares), with an additional extension equal to the number of shares repurchased under the buyback mandate.

5. Constitutional Update • Special resolution to adopt the fourth amended and restated Memorandum and Articles of Association, incorporating the amendments detailed in the company’s circular dated 16 April 2026.

Administrative Details • The share register will be closed from 14 May to 19 May 2026 (both days inclusive) to determine eligibility to attend and vote at the AGM. • Proxy forms must be lodged with Tricor Investor Services Limited by 2:00 p.m. on 17 May 2026. • Treasury shares, if any, will not carry voting rights at the AGM.

Current Board Composition (as of notice date): Executive Directors – Mr. Zhang Yu, Mr. Zhang Hui, Ms. Han Zhimei; Non-executive Director – Mr. Geng Jiaqi; Independent Non-executive Directors – Ms. Liang Jihong, Mr. Chan Peng Kuan, Mr. Li Xiaopei.